Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies
Year: 2014
Type: review
Abstract: BACKGROUND: The epilepsies are a clinically heterogeneous group of neurological disorders. Despite strong evidence for heritability, genome-wide association studies have had little success in identification of risk loci associated with epilepsy, probably because of relatively small sample sizes and insufficient power. We aimed to identify risk loci through meta-analyses of genome-wide association studies for all epilepsy and the two largest clinical subtypes (genetic generalised epilepsy and focal epilepsy). METHODS: We combined genome-wide association data from 12 cohorts of individuals with epilepsy and controls from population-based datasets. Controls were ethnically matched with cases. We phenotyped individuals with epilepsy into categories of genetic generalised epilepsy, focal epilepsy, or unclassified epilepsy. After standardised filtering for quality control and imputation to account for different genotyping platforms across sites, investigators at each site conducted a linear mixed-model association analysis for each dataset. Combining summary statistics, we conducted fixed-effects meta-analyses of all epilepsy, focal epilepsy, and genetic generalised epilepsy. We set the genome-wide significance threshold at p<1·66 × 10(-8). FINDINGS: We included 8696 cases and 26 157 controls in our analysis. Meta-analysis of the all-epilepsy cohort identified loci at 2q24.3 (p=8·71 × 10(-10)), implicating SCN1A, and at 4p15.1 (p=5·44 × 10(-9)), harbouring PCDH7, which encodes a protocadherin molecule not previously implicated in epilepsy. For the cohort of genetic generalised epilepsy, we noted a single signal at 2p16.1 (p=9·99 × 10(-9)), implicating VRK2 or FANCL. No single nucleotide polymorphism achieved genome-wide significance for focal epilepsy. INTERPRETATION: This meta-analysis describes a new locus not previously implicated in epilepsy and provides further evidence about the genetic architecture of these disorders, with the ultimate aim of assisting in disease classification and prognosis. The data suggest that specific loci can act pleiotropically raising risk for epilepsy broadly, or can have effects limited to a specific epilepsy subtype. Future genetic analyses might benefit from both lumping (ie, grouping of epilepsy types together) or splitting (ie, analysis of specific clinical subtypes). FUNDING: International League Against Epilepsy and multiple governmental and philanthropic agencies.
Source: The Lancet Neurology
Author: †
Institution: Filadelfia
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,986
Funders: GlaxoSmithKline, Sanofi, Children's Hospital of Philadelphia, Nationwide Children's Hospital, Wellcome Trust, Health Research Board, Royal Melbourne Hospital Neuroscience Foundation, Medical Research Charities Group, Epilepsy Ireland, Danish Cancer Society Research Center, National Institute for Health and Care Research, European Commission, European Science Foundation, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Fonds De La Recherche Scientifique - FNRS, Research Grants Council, University Grants Committee, Chinese University of Hong Kong, Université Libre de Bruxelles, National Institutes of Health, National Health and Medical Research Council, Seventh Framework Programme, Helmholtz Zentrum München, Münchner Zentrum für Gesundheitswissenschaften, NIHR Great Ormond Street Hospital Biomedical Research Centre, NIHR Sheffield Biomedical Research Centre, National Institute of Neurological Disorders and Stroke, National Center for Advancing Translational Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development, UCB Pharma
Awards: G1264465731, G1493675567, Epilepsy: a patient to bench back to patient program about understanding the causes of seizure disorders, G2124827803, G2149582790, G2495173109, G2567818951, G2590910600, G2898335566, G3207356259, G3294554326, Verbundprojekt Epilepsie und Migräne-Netzwerk (EMINet) - Standort Köln (Teilprojekt1, Teilprojekt3, Teilprojekt4), G387704651, G393177772, G3935138266, The Ohio State University Center for clinical and Translational Science, Genome-wide association studies in partial epilepsies., G4198644705, G4689772688, G4866040067, G4980587219, FOLATE AND NEURAL TUBE DEFECTS, G5520316217, G5702163051, G5740269239, G578322722, Epilepsy Pharmacogenomics: delivering biomarkers for clinical use, Genetic Study of Common Forms of Epilepsy, Verbundprojekt Epilepsie und Migräne-Netzwerk (EMINet) - Standort Tübingen (Teilprojekt 6), Targets and biomarkers for antiepileptogenesis, G6516092379, G6694088112, G70148952, G73802003, G7575522593, G7657769254, Zentrale Biomaterialbank der Universität Kiel: Das popgen 2.0-Netzwerk
OpenAlex ID: W2338208255
